Lily G Bessette

Nov 25, 2024 | jamanetwork.com | Lily G Bessette |Timothy Anderson

Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population Glucagon-like peptide 1 (GLP-1) receptor agonists liraglutide and semaglutide and dual GLP-1 and glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonist tirzepatide are novel treatments for weight loss.

May 21, 2024 | dialnet.unirioja.es | Karine Suissa |Richard Wyss |Zhigang Lu |Lily G Bessette

Development and Validation of a Claims-Based Model to Predict Categories of ObesityAutores: Karine Suissa, Richard Wyss, Zhigang Lu, Lily G Bessette, Cassandra York, Theodore N Tsacogianis, Kueiyu Joshua LinLocalización: American journal of epidemiology, ISSN-e 1476-6256, ISSN 0002-9262, Vol. 193, Nº. 1, 2024, págs. 203-213Idioma: inglésEnlacesTexto completo  1    2 (pdf) ResumenAbstract We developed and validated a claims-based algorithm that classifies patients into obesity categories.

Sep 2, 2023 | dovepress.com | Lily G Bessette |Daniel E. Singer |Ajinkya Pawar |Vincent Wong

Back to Journals » Clinical Epidemiology » Volume 16 Authors Bessette LG , Singer DE , Pawar A, Wong V, Kim DH , Lin KJ Received 2 September 2023 Accepted for publication 7 February 2024 Published 17 April 2024 Volume 2024:16 Pages 267—279 DOI https://doi.org/10.2147/CLEP.S438013 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Laura Horsfall Lily G Bessette,1 Daniel E Singer,2 Ajinkya Pawar,1 Vincent Wong,1 Dae...